Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis
File(s)Figure 1- Consort Flow Diagram.tif (1.47 MB) ICI GLS Supplementary Tables.docx (94.7 KB)
Supporting information
Supporting information
Author(s)
Type
Journal Article
Abstract
BACKGROUND: There is a need for improved methods for detection and risk stratification of myocarditis associated with immune checkpoint inhibitors (ICIs). Global longitudinal strain (GLS) is a sensitive marker of cardiac toxicity among patients receiving standard chemotherapy. There are no data on the use of GLS in ICI myocarditis. OBJECTIVES: This study sought to evaluate the role of GLS and assess its association with cardiac events among patients with ICI myocarditis. METHODS: This study retrospectively compared echocardiographic GLS by speckle tracking at presentation with ICI myocarditis (cases, n = 101) to that from patients receiving an ICI who did not develop myocarditis (control subjects, n = 92). Where available, GLS was also measured pre-ICI in both groups. Major adverse cardiac events (MACE) were defined as a composite of cardiogenic shock, arrest, complete heart block, and cardiac death. RESULTS: Cases and control subjects were similar in age, sex, and cancer type. At presentation with myocarditis, 61 cases (60%) had a normal ejection fraction (EF). Pre-ICI, GLS was similar between cases and control subjects (20.3 ± 2.6% vs. 20.6 ± 2.0%; p = 0.60). There was no change in GLS among control subjects on an ICI without myocarditis (pre-ICI vs. on ICI, 20.6 ± 2.0% vs. 20.5 ± 1.9%; p = 0.41); in contrast, among cases, GLS decreased to 14.1 ± 2.8% (p < 0.001). The GLS at presentation with myocarditis was lower among cases presenting with either a reduced (12.3 ± 2.7%) or preserved EF (15.3 ± 2.0%; p < 0.001). Over a median follow-up of 162 days, 51 (51%) experienced MACE. The risk of MACE was higher with a lower GLS among patients with either a reduced or preserved EF. After adjustment for EF, each percent reduction in GLS was associated with a 1.5-fold increase in MACE among patients with a reduced EF (hazard ratio: 1.5; 95% confidence interval: 1.2 to 1.8) and a 4.4-fold increase with a preserved EF (hazard ratio: 4.4; 95% confidence interval: 2.4 to 7.8). CONCLUSIONS: GLS decreases with ICI myocarditis and, compared with control subjects, was lower among cases presenting with either a preserved or reduced EF. Lower GLS was strongly associated with MACE in ICI myocarditis presenting with either a preserved or reduced EF.
Date Issued
2020-02-11
Date Acceptance
2019-11-22
Citation
Journal of the American College of Cardiology, 2020, 75 (5), pp.467-478
ISSN
0735-1097
Publisher
Elsevier
Start Page
467
End Page
478
Journal / Book Title
Journal of the American College of Cardiology
Volume
75
Issue
5
Copyright Statement
Crown Copyright © 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation. All rights reserved. Crown Copyright © 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation. All rights reserved.
Sponsor
Fondation Leducq
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/32029128
PII: S0735-1097(19)38682-6
Grant Number
19CVD02
Subjects
global longitudinal strain
immune checkpoint inhibitors
major adverse cardiac events
myocarditis
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2020-02-03